US HUPO 2026
Discovery to targeted assays for fingerprinting flow-sorted immune from healthy human donors
Ariana E. Shannon1, Robert Davenport2, Yoshi Koguichi2, Zihai Li2, Mark Rubinstein2, Amanda Berg3, Gary Valaskovic3, Helena Svobodova3, Brian C. Searle1
1Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; 2Pelotonia Institute for Immuno-Oncology, Ohio State University, Columbus, OH; 3New Objective, Inc., Littleton, MA
ASMS 2025
A Novel Nanoflow LC-MS Platform for the Robust Identification of HLA Peptides from High Value Clinical Samples
Helena Svobodova1, Gary Valaskovic1, Amanda Berg1, Reese Hitchings2, David Lewis2, Nicholas Cheung2, Robert Salzler2
1New Objective, Inc, Littleton, MA; 2Regeneron, Tarrytown, NY
Soluble APPβ and sAPPα Kinetic Curve Results are improved with utilization of a novel nanoflow LC-MS Platform
Justyna Dobrowolska Zakaria1; Helena Svobodova2; Gary Valaskovic2; Amanda Berg2; Robert J. Vassar1
1Northwestern University Feinberg School of Medicine, Chicago, IL; 2New Objective Inc, Littleton, MA
HUPO 2025
A Novel Nanoflow LC-MS Platform for the Robust Identification of HLA Peptides from High Value Clinical Samples
Helena Svobodova1, Gary Valaskovic1, Amanda Berg1, Reese Hitchings2, David Lewis2, Nicholas Cheung2, Robert Salzler2
1New Objective, Inc, Littleton, MA; 2Regeneron, Tarrytown, NY